Parties d'ouvrages collectifs (14)
  1. 1. Peretz, A., Bergmann, P., Papadopoulos, T. A., Siderova, V., & Neve, J. (2000). Effect of zinc supplementation on biological parameters of bone turnover in healthy men. In A. Roussel, R. Anderson, & A. Favier (Eds.), Trace elements in man and animals (pp. 1009-1012). New York: Plenum Press.
  2. 2. Neve, J., & Peretz, A. (1997). Trace elements in inflammatory rheumatic diseases. In I. Lombeck (Ed.), Spuren-elemente: Bedarf, vergiftungen, wechselwirkungen und neuere messmethoden (pp. 138-143). Stuttgart: Wissenschaftliche Verlagsgesellschaft mbh.
  3. 3. Neve, J., & Peretz, A. (1995). Physiological functions involving metal ions: implications of metal ions in the endocrine system. In G. Berthon (Ed.), Handbook of metal-ligand interactions in biological fluids, Vol. 2. Metal-ligand interactions in biological fluids (pp. 128-135). New York: Marcel Dekker.
  4. 4. Neve, J., & Peretz, A. (1995). Implications of metal ions in organic drug side effects: influence of corticosteroid therapy on zinc and copper metabolism. In G. Berthon (Ed.), Handbook of metal-ligand interactions in biological fluids, Vol. 2. Metal-ligand interactions in biological fluids (pp. 1466-1470). New York: Marcel Dekker.
  5. 5. Bourdoux, P., & Peretz, A. (1994). Parathyroid hormone (Parathyrin, PTH-Mid molecule), S. In W. Faulkner & S. Meites (Eds.), Geriatric clinical chemistry-Reference values (p. 449). Washington DC: American Association for Clinical Chemistry Inc.
  6. 6. Bourdoux, P., & Peretz, A. (1994). Parathyroid hormone (Parathyrin, PTH-Intact molecule), S. In W. Faulkner & S. Meites (Eds.), Geriatric clinical chemistry-Reference values (p. 447). Washington DC: American Association for Clinical Chemistry Inc.
  7. 7. Bourdoux, P., & Peretz, A. (1994). Calcitonin (Thyrocalcitonin), S. In W. Faulkner & S. Meites (Eds.), Geriatric clinical chemistry-Reference values (p. 281). Washington DC: American Association for Clinical Chemistry Inc.
  8. 8. Peretz, A., Siderova, V., & Neve, J. (1994). Trace element status and modulation of the inflammatory process in chronic rheumatic diseases. In A. Favier, J. Neve, & P. Faure (Eds.), Trace elements and free radicals in oxidative diseases (pp. 175-183). Champaign: AOCS Press.
  9. 9. Neve, J., & Peretz, A. (1989). Expression of urinary selenium levels in humans. In J. Neve & A. Favier (Eds.), Selenium in medicine and biology (pp. 189-193). Berlin: W. de Gruyter.
  10. 10. Peretz, A., Neve, J., Fontaine, J., Vertongen, F., & Famaey, J. P. (1989). Effects of corticosteroid treatment on selenium status in man and animal. In J. Neve & A. Favier (Eds.), Selenium in medicine and biology (pp. 93-96). Berlin: W. de Gruyter.
  11. 11. Peretz, A., Neve, J., & Famaey, J. P. (1988). Zinc, copper and selenium in chronic and acute inflammatory rheumatic diseases. In P. Bratter & P. Schramel (Eds.), Trace element analytical chemistry in medicine and biology (pp. 471-476). Berlin: W. de Gruyter.
  12. 12. Neve, J., Vertongen, F., Peretz, A., & Van Erum, S. (1988). Selenium status in healthy Belgian adults: assessment of adequacy by various biochemical indices and response to supplementation. In P. Bratter & P. Schramel (Eds.), Trace element analytical chemistry in medicine and biology (pp. 371-376). Berlin: W. de Gruyter.
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 Suivant >>